Recombinant multi-species NOP58 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NOP58 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a core component of box C/D small nucleolar ribonucleoproteins. Some box C/D small nucleolar RNAs (snoRNAs), such as U3, U8, and U14, are dependent upon the encoded protein for their synthesis. This protein is SUMOylated, which is necessary for high affinity binding to snoRNAs. [provided by RefSeq, Nov 2015]
The Alternative Names of target: HSPC120,MSSP,NOP5,NOP5/NOP58,NOP58,Nap65,Nol5,Nop58,Nucleolar protein 5,Nucleolar protein 58,SIK,nop5

Target products collectionGo to NOP58 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9493-Ag-1/ GM-Tg-hg-IP9493-Ag-2 Human NOP58 protein Human
GM-Tg-rg-IP9493-Ag-1/ GM-Tg-rg-IP9493-Ag-2 Rat NOP58 protein Rat
GM-Tg-mg-IP9493-Ag-1/ GM-Tg-mg-IP9493-Ag-2 Mouse NOP58 protein Mouse
GM-Tg-cynog-IP9493-Ag-1/ GM-Tg-cynog-IP9493-Ag-2 Cynomolgus/Rhesus macaque NOP58 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9493-Ag-1/ GM-Tg-felg-IP9493-Ag-2 Feline NOP58 protein Feline
GM-Tg-cang-IP9493-Ag-1/ GM-Tg-cang-IP9493-Ag-2 Canine NOP58 protein Canine
GM-Tg-bovg-IP9493-Ag-1/ GM-Tg-bovg-IP9493-Ag-2 Bovine NOP58 protein Bovine
GM-Tg-equg-IP9493-Ag-1/ GM-Tg-equg-IP9493-Ag-2 Equine NOP58 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9493-Ag-1/ GM-Tg-hg-IP9493-Ag-2; GM-Tg-rg-IP9493-Ag-1/ GM-Tg-rg-IP9493-Ag-2;
GM-Tg-mg-IP9493-Ag-1/ GM-Tg-mg-IP9493-Ag-2; GM-Tg-cynog-IP9493-Ag-1/ GM-Tg-cynog-IP9493-Ag-2;
GM-Tg-felg-IP9493-Ag-1/ GM-Tg-felg-IP9493-Ag-2; GM-Tg-cang-IP9493-Ag-1/ GM-Tg-cang-IP9493-Ag-2;
GM-Tg-bovg-IP9493-Ag-1/ GM-Tg-bovg-IP9493-Ag-2; GM-Tg-equg-IP9493-Ag-1/ GM-Tg-equg-IP9493-Ag-2
Products Name NOP58 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NOP58
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NOP58 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.